Literature DB >> 1289741

Investigation of stroke in sickle cell disease by 1H nuclear magnetic resonance spectroscopy.

Z Wang1, A R Bogdan, R A Zimmerman, D A Gusnard, J S Leigh, K Ohene-Frempong.   

Abstract

Localized proton nuclear magnetic resonance spectroscopy (MRS), obtained with stimulated echo and spin echo sequences, MR imaging (MRI) and MR angiography (MRA) were used to study the brain in 13 children and adolescents with sickle cell disease. Regions of interest (ROI) studied by MRS included regions appearing normal on MRI as well as regions showing complications of sickle cell disease, including focal deep white matter areas of high signal intensity (deep white matter ischemia, DWMI) seen on long TR images, focal atrophic brain areas, and infarcts. The findings in these studies are summarized as follows: Normal-appearing regions on MRI have normal MRS. In ROI including small areas of DWMI, lactate elevation was not detected, but the levels of N-acetyl-aspartate (NAA) appeared slightly elevated. In areas of DWMI 1-2 cm in size, reduced blood flow could be seen on MRA and lactate elevation could be detected with MRS. When blood flow to a DWMI region was normal, NAA was reduced and there was little lactate elevation, as cell death had already occurred. ROI consisting of atrophic tissue had reduced NAA levels but total creatine levels were not changed. Sometimes lipids, presumably from broken cell membrane, could be detected. In regions of past massive stroke, all metabolites were absent except for small amounts of lactate or lipids.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1289741     DOI: 10.1007/bf00588281

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  21 in total

1.  On the N-acetyl methyl resonance in localized 1H NMR spectra of human brain in vivo.

Authors:  J Frahm; T Michaelis; K D Merboldt; W Hänicke; M L Gyngell; H Bruhn
Journal:  NMR Biomed       Date:  1991-08       Impact factor: 4.044

Review 2.  Stroke in sickle cell disease: demographic, clinical, and therapeutic considerations.

Authors:  K Ohene-Frempong
Journal:  Semin Hematol       Date:  1991-07       Impact factor: 3.851

3.  In vivo proton spectroscopy in presence of eddy currents.

Authors:  U Klose
Journal:  Magn Reson Med       Date:  1990-04       Impact factor: 4.668

4.  Occlusion of large cerebral vessels in sickle-cell anemia.

Authors:  J A Stockman; M A Nigro; M M Mishkin; F A Oski
Journal:  N Engl J Med       Date:  1972-10-26       Impact factor: 91.245

Review 5.  N-acetyl-L-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain.

Authors:  D L Birken; W H Oldendorf
Journal:  Neurosci Biobehav Rev       Date:  1989       Impact factor: 8.989

6.  Serial proton magnetic resonance spectroscopy of ischemic brain injury in humans.

Authors:  M J Fenstermacher; P A Narayana
Journal:  Invest Radiol       Date:  1990-09       Impact factor: 6.016

7.  Clinical MRS studies of the brain.

Authors:  B Hubesch; D S Marinier; H P Hetherington; D B Twieg; M W Weiner
Journal:  Invest Radiol       Date:  1989-12       Impact factor: 6.016

8.  High-resolution proton magnetic resonance analysis of human cerebrospinal fluid.

Authors:  O A Petroff; R K Yu; T Ogino
Journal:  J Neurochem       Date:  1986-10       Impact factor: 5.372

9.  Chronic adult cerebral infarction studied by phosphorus NMR spectroscopy.

Authors:  P A Bottomley; B P Drayer; L S Smith
Journal:  Radiology       Date:  1986-09       Impact factor: 11.105

10.  Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites.

Authors:  J Frahm; H Bruhn; M L Gyngell; K D Merboldt; W Hänicke; R Sauter
Journal:  Magn Reson Med       Date:  1989-07       Impact factor: 4.668

View more
  2 in total

1.  Abnormally high levels of brain N-acetylaspartate in children with sickle cell disease.

Authors:  R Grant Steen; Robert J Ogg
Journal:  AJNR Am J Neuroradiol       Date:  2005-03       Impact factor: 3.825

2.  Multiple complications in a sickle cell disease patient: a case report.

Authors:  J A Olaniyi
Journal:  Clin Med Case Rep       Date:  2008-07-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.